This is a working overview of gastric juice protein, written for readers who want more than a one-paragraph summary but less than a textbook.
Reviewed 2026-03-22. Anything still debated is marked as such rather than presented as settled.
BPC-157 is a synthetic peptide built from fifteen amino acids, referred to in the literature as a pentadecapeptide. Its sequence was derived from a larger protein found in human gastric juice, commonly called body protection compound. Researchers first described the fragment in the early 1990s and named it after the parent protein plus a numeric identifier. The peptide does not correspond to a single marketed medicine; it is primarily a laboratory research material. Suppliers distribute it as a lyophilized powder intended for experimental use.
Published work on BPC-157 spans several decades and covers a wide range of experimental models. Much of the early literature reports outcomes in animal studies involving induced injury to the gastrointestinal tract, tendons, and other tissues. The volume of preclinical reports is large, while controlled human trials remain scarce. This imbalance is a recurring point of discussion, because animal findings do not automatically translate into human effects. Reviews often note that study designs differ substantially across laboratories.
Interest in the peptide has grown through online communities that discuss self-administered use, which sits outside formal research settings. Regulatory status varies by country, and in many jurisdictions the compound is not approved as a therapeutic product. Questions about optimal routes of administration, long-term effects, and dose-response relationships remain open. Published pharmacokinetic data in humans are limited, and much of what circulates in popular discussion is extrapolated from animal work rather than measured directly in people.
BPC-157 is a synthetic peptide of fifteen amino acids, written as GEPPPGKPADDAGLV, whose sequence matches part of a larger protein identified in human gastric juice. That parent protein was described in stomach-secretion research, and the fifteen-residue fragment was named body protection compound, which gives the peptide its common label. Material used in experiments is produced by solid-phase peptide synthesis rather than extracted from tissue. The reported molecular weight is about 1419 daltons, and the chain contains several proline residues, a feature that appears in discussions of its resistance to enzymatic breakdown.
Most published findings come from rodent models, where the peptide has been examined in wound-healing, gastrointestinal-lesion, tendon, and vascular-injury preparations. A smaller number of early human studies have been reported, chiefly in inflammatory bowel conditions, but the public record is short and has not led to marketing approval in the United States or the European Union. Reviewers therefore classify the compound as investigational, and whether animal results carry over to people remains an open question rather than a settled one.
| Property | Value | Notes |
|---|---|---|
| Chemical class | Synthetic pentadecapeptide | Fifteen amino acids; sequence matches a fragment of a gastric juice protein |
| Molecular formula | C62H98N16O22 | Corresponds to a molecular mass near 1419 Da |
| Primary origin | Fragment of human gastric juice protein BPC | First characterized in the early 1990s |
| Common synonyms | BPC 157; PL 14736; pentadecapeptide BPC 157 | Naming conventions vary across publications |
| Reported stability | Stable in gastric juice during in vitro incubation | Based on laboratory incubation, not clinical data |
The sequence places several glycine and proline residues near the middle, which may influence how the chain folds in solution. The peptide is linear rather than cyclic, and it carries no disulfide bridges. Commercial material is commonly supplied as the acetate salt, although the free base and other counterion forms also appear. Because the term BPC-157 refers to a specific sequence, samples with slight sequence variants are chemically different substances. Published work generally treats the fifteen-residue sequence as the defining structure.
Physical descriptions in supplier documents and papers usually list the compound as a white to off-white powder. It dissolves readily in water and in common aqueous buffers, and solutions are often prepared fresh before an experiment. Molecular mass near 1419 daltons helps verify identity during mass spectrometry. The powder is somewhat hygroscopic, so moisture exposure can alter the measured mass of a sample. Purity is typically reported as a percentage from chromatographic analysis.
Published storage guidance follows general peptide practice rather than product-specific studies. The dry powder is typically kept at minus 20 degrees Celsius, away from light and moisture. Once reconstituted, solutions are generally refrigerated and used over days to weeks, because the aqueous environment slowly promotes hydrolysis and oxidation. Long-term data on degradation rates or breakdown products are sparse. Stated shelf lives from different producers vary widely, reflecting the absence of a shared reference standard.
BPC-157 is a synthetic peptide built from fifteen amino acid residues. Its sequence comes from a larger protein fragment that researchers isolated from human gastric juice and described as a body protection compound. The fragment contains glycine, glutamic acid, five prolines, lysine, alanine, two aspartic acids, leucine, and valine. The number 157 in the name refers to the position of the stretch within the parent protein. Material used in laboratories is manufactured rather than extracted from stomach fluid.
The molecule carries 15 residues, a molar mass near 1419.5 g/mol, and the formula C62H98N16O22. Its structure features a proline-rich central region, a pair of adjacent aspartic acid residues, and no cysteine. The absence of cysteine means no disulfide bonds can form, which simplifies refolding and reconstitution. Suppliers usually ship the material as a freeze-dried powder that appears white to off-white. It dissolves readily in water and in saline solutions.
Most early work on this peptide originated in the 1990s from a research group in Zagreb, Croatia, relying on animal models and cell cultures. Reported observations included effects on gastrointestinal lesion healing, tendon fibroblast migration, and blood vessel formation under controlled laboratory conditions. These findings come predominantly from rodent studies and in vitro assays rather than from human trials. Controlled human data remain limited, and the degree to which animal results translate to human physiology is an open question rather than a settled fact.
Within the research literature, the peptide is discussed through several provisional mechanisms, including cytoprotection, modulation of growth factor signaling, and interaction with the nitric oxide system. None of these mechanisms is fully characterized, and no single pathway is universally accepted. Review articles typically note the gap between consistent animal findings and sparse human evidence. The compound is classified as a research chemical rather than an approved pharmaceutical, which shapes how studies are designed, funded, and reported.
The governments of these regions, which had their origins in the juntas of 1810, and even moderates there, who had entertained a reconciliation with the crown, now saw the need to separate from Spain if they were to protect the reforms they had enacted.
== Chemical reactions == Being multifunctional, cysteine undergoes a variety of reactions. Much attention has focused on protecting the thiol group. Methylation of cysteine gives S-methylcysteine. Treatment with formaldehyde gives the thiazolidine thioproline. With phosgene and related carbonylating agents, cysteine gives procysteine. Cysteine forms a variety of coordination complexes upon treatment with metal ions. This coordination behavior is seen in many metal-cysteine metalloenzymes.
==== MeSH E05.820.800 – reproductive techniques, assisted ==== MeSH E05.820.800.500 – embryo transfer MeSH E05.820.800.750 – fertilization in vitro MeSH E05.820.800.750.700 – sperm injections, intracytoplasmic MeSH E05.820.800.800 – posthumous conception MeSH E05.820.800.875 – gamete intrafallopian transfer MeSH E05.820.800.937 – insemination, artificial MeSH E05.820.800.937.515 – insemination, artificial, heterologous MeSH E05.820.800.937.525 – insemination, artificial, homologous MeSH E05.820.800.968 – oocyte donation MeSH E05.820.800.984 – ovulation induction MeSH E05.820.800.984.500 – superovulation MeSH E05.820.800.992 – zygote intrafallopian transfer
Sources: en.wikipedia.org
March 12, 2010: Canada 21,000 jobs were created in Canada as of February 2010. However, employers are still not hiring people in most places including Stelco and other jobs that are in rural areas like Norfolk County, Ontario.
== Recombinant protein-based textiles == Collagen, fibroin, gelatin, casein, and actin are naturally from animal products. Collagen and silk are the most attractive biopolymers for developing biotextiles. Collagen can be produced from a plethora of organisms and renewable sources. Collagen's repeating amino acid sequence allows it to form a stable secondary protein structure of triple helices. These helices can further assemble into quaternary structures, allowing collagen to take on the form of fibrillar proteins. These protein building blocks could biofabricate abrasion-resistant, water-resistant, breathable, lightweight and durable materials with characteristics similar to leather. Natural silk has remarkable strength. The fibroin protein in silk consists of long, repetitive chains of amino acids, predominantly glycine, alanine, and serine. These amino acids are arranged in a specific sequence, forming a unique molecular structure that contributes to silk's remarkable properties. Silk has high tensile strength that can be attributed to its nano-crystalline and molecular structure (hydrogen bonds & β-sheet structure) and high degree of orientation. Significant efforts have been made to obtain recombinant silk fibroin, principally from the spider, dragline, or silkworm through genetic alteration. The developed protein is later isolated and processed into threads by techniques such as spinning.
== Recent developments == In 2025, media reports indicated continued competition over milk quotas, with some agricultural colleges losing supplier rights under revised regulations. Later the same year, the Cabinet of Thailand approved an additional 800 million baht in emergency funds to address issues of stockpiled UHT milk and delayed deliveries.
Extremophile – Organisms capable of living in extreme environments Ombrophobe – Plant adverse to rainfall Osmophile – Organism tolerant osmotic effects from a low water activity Xerocole – Any animal adapted to live in the desert Xerophyte – A plant adapted to a hot dry environment
Sources: en.wikipedia.org
It is a synthetic peptide of fifteen amino acids whose sequence matches a fragment of a protein found in human gastric juice. It is studied mainly in laboratory and animal research rather than as an approved medicine.
The letters abbreviate body protection compound, the name given to the parent protein isolated from gastric juice. The number is an identifier attached to the specific fragment, not a dose or a description of a chemical property.
The sequence corresponds to a segment of an endogenous gastric protein, but the isolated fifteen-amino-acid peptide is a synthetic construct. Whether the free fragment circulates in humans at measurable levels is not clearly established in the published literature.
It is not approved for human use in the United States or the European Union. Clinical material has been studied in a small number of early trials, mainly for inflammatory bowel conditions, and the compound remains investigational. Regulators treat marketed products as unapproved rather than as authorized drugs.